iTolerance CEO, Anthony Japour, Receives BioFlorida's Research & Developer of the Year Award

November 12, 2025 10:00 AM

iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced that Anthony Japour, Chief Executive Officer and President of iTolerance, received the Research & Developer of the Year Award at the recently held BioFlorida Innovation Conference in Miami, FL. "We are honored that BioFlorida has recognized our team's work and...

Read more

U.S. Hospitals Underfund AI Governance as Adoption Accelerates

November 12, 2025 9:00 AM

A new Black Book Research survey of 182 U.S. hospital leaders reveals widespread underinvestment in AI governance, safety, and compliance heading into 2026. Although artificial intelligence continues to expand across clinical and operational workflows, the median 2026 budget share for AI governance and safety is just 4.2%, and only 22% of hospitals report high confidence that they could deliver a complete, auditable AI explanation within 30 days...

Read more

Pace Surgical Receives FDA 510(k) Clearance for Ultra Compression Screw System for Foot and Ankle Reconstruction

November 12, 2025 8:10 AM

Pace Surgical, a Runway Healthcare portfolio company pioneering advancements in lower extremity fixation, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Ultra Compression Screw System™, indicated for the internal fixation and stabilization of arthrodesis, osteotomies, fractures, and nonunion of the foot and ankle.The Ultra Compression Screw System introduces a patent-pending approach to...

Read more

Donath Facial Plastic Surgery Announces Annual Open House

November 12, 2025 8:00 AM

Donath Facial Plastic Surgery has announced the return of its annual Fabulous Friday Open House, a much-anticipated community event offering patients and guests exclusive savings, giveaways, and an inside look at the practice's full range of surgical and non-surgical facial rejuvenation services. The event will take place on Friday, November 14, 2025, featuring both in-person and online participation options.The in-person open house will be held...

Read more

Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line

November 12, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies targeting the epigenetic roots of cancer, aging, and age-related disease, today announced new preclinical findings showing that its lead investigational compound Telomir-1 produced a strong, dose-dependent reduction of intracellular iron in human keratinocyte (HaCaT) cells - outperforming the FDA-approved...

Read more

Wellgistics Health Launches EinsteinRx as the Premier AI Prescription Management Hub Solution to Integrate Physical and Technology Healthcare Infrastructure

November 12, 2025 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in the integration of physical and technology healthcare infrastructure for prescription drugs, today announced that it has launched EinsteinRx™, the premier prescription management solution to integrate physical and technology infrastructure for the prescription drug industry. EinsteinRx allows for the fully customizable, seamless flow of information from the physician to the...

Read more

Robert A. Winn Excellence in Clinical Trials Award Program Announces 2025 Awardees for the Winn Career Development Award

November 12, 2025 7:00 AM

Originally published by The Robert A. Winn Excellence in Clinical Trials Award ProgramThe Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards) recently announced 79 new physician-researchers from across the United States have been selected to join the fifth annual cohort of the Winn Career Development Award (Winn CDA) program, a rigorous two-year curriculum designed to advance community-focused clinical research.The Winn...

Read more

CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth

November 12, 2025 7:00 AM

CBD Life Sciences Inc. (OTC Pink:CBDL) proudly announces another significant order from Smoking Scholars, the rapidly growing dispensary located in the Bronx, New York - further solidifying CBDL's position as one of the most active and fast-expanding players in the cannabis and CBD marketplace.Following the success of its previous headline-making partnership earlier this quarter, Smoking Scholars has placed a new bulk order featuring an elite...

Read more

Smith County Medical Society Announce Inaugural Duane N. Andrews, MD, Compassion in Medicine Memorial Lecture & Grand Rounds

November 12, 2025 7:00 AM

Smith County Medical Society is honored to announce the inaugural Duane N. Andrews, MD, Compassion in Medicine Memorial Lecture & Grand Rounds. This event will be held on Friday, November 14, 2025, at 12:00PM at the Ornelas Academic Amphitheater at the UT Tyler Health Science Center (11937 U.S. Hwy. 271 in Tyler) in honor of Dr. Duane Neil Andrews, who passed away on June 1, 2024, at the age of 86. Dr. Andrews was a brilliant surgeon who was...

Read more

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

November 12, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will be participating in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Wednesday, November 19th, 2025, at 3:30 pm GMT. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the...

Read more

DGS Healthcare Redefines Marketing and Technology Solutions for the Healthcare Industry

November 12, 2025 4:45 AM

DGS Healthcare, an innovation-driven company specializing in healthcare-focused marketing, telesales, and software solutions, is transforming the way healthcare organizations connect with patients and drive growth.Unlike traditional marketing agencies that focus primarily on brand visibility, DGS Healthcare is built around measurable outcomes - turning awareness into real patient acquisition, sales, and profitability. This results-oriented...

Read more

Cantargia Presents Nomination Committee Ahead of 2026 AGM

November 12, 2025 3:00 AM

Cantargia (STO:CANTA) - Cantargia AB (publ) (Nasdaq Stockholm:CANTA) today provided notification that the Nomination Committee (NC) has been appointed ahead of the 2026 Annual General Meeting (AGM). It is composed of Arne Lööw (Fjärde AP-fonden), Henrick Schill, Lars H. Bruzelius (Brushamn Invest AB) and Magnus Persson (Chairman of the Board). The NC has been appointed in accordance with the guidelines established at the 2023 AGM.As of September...

Read more

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

November 12, 2025 2:00 AM

Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced that it has received a US$ 5 m milestone payment from Bristol Myers Squibb, following the acceptance of an Investigational New Drug ("IND") application by the U.S. Food and Drug Administration ("FDA") in their strategic protein degradation partnership. The drug candidate, a cereblon E3 ligase modulator ("CELMoD™")...

Read more

2026 Health System AI Governance Resource Guide: Black Book Global Benchmark and Regulatory Readiness Report

November 11, 2025 6:00 PM

Black Book Research has released the 2026 Health System & Hospital AI Governance Resource Guide, the first in a new Board-level research series that will guide health systems through the evolving landscape of HIT decision-making, funding, AI oversight, regulation, and accountability in 2026.This open-access global benchmark report translates the complexity of AI governance into a practical operating framework defining board decision rights,...

Read more

Vituity Expands Into Radiology With the Integration of Focus Medical Imaging

November 11, 2025 11:00 AM

Vituity, a physician-owned and led multispecialty partnership, is proud to announce its entry into the radiology space, welcoming Focus Medical Imaging (FMI). The move establishes radiology as Vituity's newest specialty, furthering its mission to deliver integrated, physician-driven care across the acute care continuum.Radiology plays a crucial role in providing timely and accurate care. Yet hospitals and health systems across the country...

Read more

Precise Introduces the First Unified Behavioral Health Operating System BOS Servicing the Complete Care Continuum

November 11, 2025 11:00 AM

Precise Behavioral, a leading tech-enabled Behavioral Health company serving Health Systems, Skilled Nursing Facilities, Correctional Facilities, ACOs and Medical Groups, announced today the launch of their Behavioral Health Operating System, BOS, an integrated platform that supports the complete continuum of care for patients needing behavioral health services and treatments. A single system that addresses clinical, financial and technology...

Read more

Ameerex Corporation Confirms Entry into the U.S. Oil Market Through British Joint Venture Falcon Caddo Venture to Reach 5,000 Barrels per Day in Texas

November 11, 2025 10:05 AM

AMEEREX Corporation (OTC:HIRU), formerly HIRU Corporation, confirmed its official participation in the U.S. energy market through a strategic joint venture with a British energy partner, acquiring an initial 40% equity participation in Falcon Caddo Venture LLC, operator of the Rasberry Unit Field Project in Texas.Ameerex's participation is structured to increase during subsequent development phases, with production on track to reach...

Read more

Alpha Genesis Expands U.S. Primate Breeding Operations by 40% to Advance U.S. Scientific Self-Reliance

November 11, 2025 9:00 AM

Alpha Genesis, Inc. (AGI), a leading U.S. provider of nonhuman primates and biomedical research services, has expanded its South Carolina breeding operations by 40 percent to reduce the costs, delays, and uncertainties associated with imported research animals. The expansion adds 1,200 new research-ready spaces and allows AGI to offer the most competitive animal pricing, per-diem rates, and lead times in the industry, strengthening America's...

Read more

CLS Health Celebrates 20 Years of Delivering Physician-Led, Patient-Centered Care

November 11, 2025 9:00 AM

Two decades ago, CLS Health was created as a physician-owned, physician-led healthcare system to serve the Greater Houston area, placing clinical decision-making in the hands of physicians. Now, having grown to more than 225 doctors and healthcare professionals across 45 medical specialties, CLS Health is marking its anniversary on October 26 with community events, charitable initiatives, and stories about physician leadership in improving care...

Read more

Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025

November 11, 2025 8:45 AM

Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company developing new medicines to treat pain and neuropathy, today announced it has successfully enrolled the first 100 patients in its ongoing HALT-CINP Phase 2b CINP trial. HALT-CINP remains on track to conduct a prespecified interim analysis during the fourth quarter of 2025 on patients who have completed or been terminated from the four-week...

Read more